Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

BM 13505

Known as: BM 13.505, BM-13505 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

daltroban

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
Antithrombotic effects in a rat model of aspirin-insensitive arterial thrombosis of desethyl KBT-3022, the main active metabolite of a new antiplatelet agent, KBT-3022.
The antithrombotic effect of desethyl KBT-3022, which is the main active metabolite of the new antiplatelet agent, KBT-3022… Expand
Is this relevant?
1995
1995
Platelet-activating factor increases vascular resistance in rat hindquarters by thromboxane A2.
The effects of platelet-activating factor (PAF) on vascular resistance and capillary permeability were studied in the isolated… Expand
Is this relevant?
1994
1994
Endothelin-1-induced myocardial ischaemia and oedema in the rat: involvement of the ETA receptor, platelet-activating factor and thromboxane A2.
1. The objectives of the present experiments were to assess the role of ETA receptors in mediating endothelin-1 (ET-1)-induced… Expand
Is this relevant?
1993
1993
Inhibitory effect of KW-3635, a new thromboxane A2-receptor antagonist, on arterial thrombosis in guinea pigs.
The antithrombotic effects of the thromboxane (TX) A2-receptor antagonist and aspirin were determined using a photochemically… Expand
Is this relevant?
1993
1993
[Effects of KW-3635 on the diuretic action of furosemide in rats].
The effects of KW-3635 (sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl) ethylidene]-6,11-dihydrodibenz-[b,e]oxepine-2… Expand
Is this relevant?
1992
1992
Endothelin-1 enhances vascular permeability in conscious rats: role of thromboxane A2.
The purpose of the present experiments was to study the effects of endothelin-1 (ET-1) on vascular permeability and the… Expand
Is this relevant?
1992
1992
Differences in activities of thromboxane A2 receptor antagonists in smooth muscle cells.
Thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptors were characterized in rat vascular smooth muscle cells (VSMC). The specific… Expand
Is this relevant?
1989
1989
Protective effect of the specific thromboxane receptor antagonist, BM-13505, in reperfusion injury following acute myocardial ischemia in cats.
The ability of BM-13505, 4-[2-(4-chlorobenzenesulfonylamino) ethyl]-benzene acetic acid), a specific thromboxane/endoperoxide… Expand
Is this relevant?
1988
1988
Protective effects of thromboxane receptor blockade in splanchnic artery occlusion shock.
Splanchnic artery occlusion (SAO) followed by release of the occlusive clamps produces circulatory shock characterized by an… Expand
Is this relevant?
1986
1986
Beneficial actions of thromboxane receptor antagonism in hemorrhagic shock.
The new specific thromboxane receptor antagonist, BM-13505, was infused intravenously (1 mg/kg bolus and 1 mg/kg hr continuous… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE